For citations:
Shadrina V.V., Kondratyeva E.I., Voronkova A.Yu., Zhekaite E.K., Krasovskiy S.A., Amelina E.L., Orlov A.V., Pinegina Yu.S., Lavrova A.E., Trishina S.V., Abdulganieva D.I., Semykin S.Yu., Vlasova A.V. Results of a prospective open observational study of the use of dornase alfa as part of complex therapy for patients with cystic fibrosis. PULMONOLOGIYA. 2024;34(2):206-217. (In Russ.) https://doi.org/10.18093/0869-0189-2024-34-2-206-217